Rush Enterprises Inc – Class A (NASDAQ:RUSHA) had a decrease of 0.12% in short interest. RUSHA’s SI was 423,600 shares in November as released by FINRA. Its down 0.12% from 424,100 shares previously. With 171,400 avg volume, 3 days are for Rush Enterprises Inc – Class A (NASDAQ:RUSHA)’s short sellers to cover RUSHA’s short positions. The SI to Rush Enterprises Inc – Class A’s float is 1.52%. The stock increased 0.57% or $0.25 during the last trading session, reaching $43.94. About 266,969 shares traded. Rush Enterprises, Inc. (NASDAQ:RUSHA) has declined 14.02% since November 4, 2018 and is downtrending. It has underperformed by 14.02% the S&P500. Some Historical RUSHA News: 23/04/2018 – RUSH ENTERPRISES 1Q EPS 51C, EST. 47C; 14/03/2018 Rush Enterprises, Inc. Increases Stk Repurchase Program by $35 M; 19/04/2018 – Rush Enterprises Closes Above 50-Day Moving Average: Technicals; 23/04/2018 – RUSH ENTERPRISES 1Q REV. $1.24B, EST. $1.19B; 15/05/2018 – Rush Enterprises May Benefit, Industry Posts 14th Straight Gain; 19/04/2018 – DJ Rush Enterprises Inc Class A, Inst Holders, 1Q 2018 (RUSHA); 14/05/2018 – T Rowe Price Associates Exits Position in Rush Enterprises; 28/03/2018 – Detailed Research: Economic Perspectives on Hub Group, Rush Enterprises, San Juan Basin Royalty Trust, Meredith, Minerals Techn; 24/04/2018 – Rush Enterprises Volume Jumps More Than Eight Times Average; 10/04/2018 – Rush Enterprises, Inc. Conference Call Advisory for First Quarter of 2018 Earnings Results
FibroGen, Inc. (FGEN) formed multiple bottom with $36.42 target or 9.00% below today’s $40.02 share price. FibroGen, Inc. (FGEN) has $3.48 billion valuation. The stock increased 2.22% or $0.87 during the last trading session, reaching $40.02. About 728,986 shares traded. FibroGen, Inc. (NASDAQ:FGEN) has declined 23.40% since November 4, 2018 and is downtrending. It has underperformed by 23.40% the S&P500. Some Historical FGEN News: 09/05/2018 – FibroGen 1Q Loss/Shr 50c; 31/05/2018 – ASTELLAS PHARMA INC – SAFETY PROFILE OF ROXADUSTAT WAS CONSISTENT WITH THAT OBSERVED IN PREVIOUS STUDIES BOTH IN DIALYSIS AND NON-DIALYSIS PATIENTS; 18/04/2018 – The Andes Summit: More Than Ayahuasca – A Re-Validation of the Cultural Heritage of Ecuador’s Ancient Indigenous Wisdom; 06/04/2018 – HK Bourse: Announcement From Pacific Andes International Holdings Ltd; 21/05/2018 – FibroGen Presents Latest Data From PRAISE Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis at American Thoracic Society 2018; 09/05/2018 – FibroGen 1Q Rev $31.9M; 31/05/2018 – ASTELLAS & FIBROGEN ANNOUNCE TOPLINE RESULTS FROM DOUBLE-BLIND JAPAN PHASE 3 STUDY FOR ROXADUSTAT IN HEMODIALYSIS CHRONIC KIDNEY DISEASE PATIENTS WITH ANEMIA; 07/05/2018 – RESOURCE CAPITAL FUND Vl L.P. ANNOUNCES ACQUISITION OF UNITS IN LOS ANDES COPPER LTD; 28/03/2018 – Andes Technology Corp. to Present & Exhibit at Design & Reuse IP SOC Conference; 09/05/2018 – FIBROGEN 1Q LOSS/SHR 50C, EST. LOSS/SHR 51C
Analysts await FibroGen, Inc. (NASDAQ:FGEN) to report earnings on November, 14. They expect $-0.59 EPS, down 18.00% or $0.09 from last year’s $-0.5 per share. After $1.26 actual EPS reported by FibroGen, Inc. for the previous quarter, Wall Street now forecasts -146.83% negative EPS growth.
More notable recent Rush Enterprises, Inc. (NASDAQ:RUSHA) news were published by: Nasdaq.com which released: “Rush Enterprises Inc (RUSHB) (RUSHA) Q3 2019 Earnings Call Transcript – Nasdaq” on October 25, 2019, also Seekingalpha.com with their article: “Wall Street Brunch – Seeking Alpha” published on November 03, 2019, Seekingalpha.com published: “More on Rush Enterprises Q3 results – Seeking Alpha” on October 24, 2019. More interesting news about Rush Enterprises, Inc. (NASDAQ:RUSHA) were released by: Nasdaq.com and their article: “Key Factors to Impact Williams Companies’ (WMB) Q3 Earnings – Nasdaq” published on October 25, 2019 as well as Nasdaq.com‘s news article titled: “3 Things to Watch for in AMD Stock’s Q3 Earnings – Nasdaq” with publication date: October 25, 2019.
Rush Enterprises, Inc., through its subsidiaries, operates as an integrated retailer of commercial vehicles and related services in the United States. The company has market cap of $1.58 billion. The firm operates a network of commercial vehicle dealerships under the Rush Truck Centers name. It has a 10.16 P/E ratio. The Company’s Rush Truck Centers primarily sell commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, Mitsubishi Fuso, IC Bus, or Blue Bird; provides new and used commercial vehicles, and aftermarket parts, as well as service and repair, financing, and leasing and rental services; and offers property and casualty insurance, including collision and liability insurance on commercial vehicles, cargo insurance, and credit life insurance to its commercial vehicle customers.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.